{"data":{"id":"us/42-cfr-2.36","jurisdiction":"us","citation":"42 CFR 2.36","heading":"Disclosures to prescription drug monitoring programs.","body":"A part 2 program or other lawful holder is permitted to report any SUD medication prescribed or dispensed by the part 2 program to the applicable state prescription drug monitoring program if required by applicable state law. A part 2 program or other lawful holder must obtain patient consent to a disclosure of records to a prescription drug monitoring program under § 2.31 prior to reporting of such information.","path":["Title 42—Public Health","CHAPTER I—PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER A—GENERAL PROVISIONS","PART 2—CONFIDENTIALITY OF SUBSTANCE USE DISORDER PATIENT RECORDS","Subpart C—Uses and Disclosures With Patient Consent"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-42.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:26:11Z","sha256":"3f773035ce91b85e42dd63fe9834752cce0822fb66470df8539a3ad2a2c8dd32","source_id":"us-cfr","stale":true,"prev":"us/42-cfr-2.35","next":"us/42-cfr-2.51"},"notice":"GroundRules: Original legal text. Not legal advice."}